Charles S Elmore et al.
Journal of labelled compounds & radiopharmaceuticals, 57(5), 342-349 (2014-04-05)
In support of a program to develop an alpha 7 agonist as a treatment for Alzheimer's disease, three drug candidates, 1, 2, and 3, were prepared in labeled forms. Compound 1 was prepared in C-14 labeled form by lithiation of